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Abstract
Haploinsufficiency of part of human chromosome 21 results in a rare condition known as Monosomy 21. This disease
displays a variety of clinical phenotypes, including intellectual disability, craniofacial dysmorphology, skeletal and cardiac
abnormalities, and respiratory complications. To search for dosage-sensitive genes involved in this disorder, we used
chromosome engineering to generate a mouse model carrying a deletion of the Lipi–Usp25 interval, syntenic with 21q11.2-
q21.1 in humans. Haploinsufficiency for the 6 genes in this interval resulted in no gross morphological defects and
behavioral analysis performed using an open field test, a test of anxiety, and tests for social interaction were normal in
monosomic mice. Monosomic mice did, however, display impaired memory retention compared to control animals.
Moreover, when fed a high-fat diet (HFD) monosomic mice exhibited a significant increase in fat mass/fat percentage
estimate compared with controls, severe fatty changes in their livers, and thickened subcutaneous fat. Thus, genes within
the Lipi–Usp25 interval may participate in memory retention and in the regulation of fat deposition.
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Introduction
The triplication of human chromosome 21, or subsets of genes
mapped to the long arm of this chromosome, is known as Trisomy
21 or Down syndrome. In contrast, haploinsufficiency of genes on
human chromosome 21 results in Monosomy 21. Complete
Monosomy 21 typically results in prenatal death [1,2], thus most
cases that have been described are of partial or mosaic monosomy.
Clinical phenotypes observed in patients with partial monosomies
of chromosome 21 are very heterogeneous. Some patients show
only mild to moderate intellectual disability, and have no other
apparent dysmorphic or congenital malformations [3,4], while
others are diagnosed with a variety of severe clinical symptoms,
such as profound intellectual disability, microcephaly, epilepsy,
craniofacial, skeletal, cardiac and/or renal abnormalities and/or
respiratory difficulties [5,6,7,8,9].
To date, four comprehensive studies have been performed using
array comparative genomic hybridization (aCGH) and high-density
single nucleotide polymorphism (SNP) genotyping to define the
breakpoint regions present in patients with Monosomy 21, and to
correlate these breakpoints with phenotype [7,8,9,10]. However, it
is clear from these studies that there is no direct correlation between
the severity of the phenotype and the genes deleted; at least for
patients carrying deletions proximal to the centromere (from the
centromere to ,31.2 Mb) and in the ‘‘medial’’ region of the
chromosome (31.2–36 Mb). Patients carrying deletions proximal to
the telomere (from ,36237.5 Mb to the telomere) typically show
less severe clinical features (including mild to moderate intellectual
disability, and either the complete absence of or only minor
craniofacial abnormalities). Thus further investigation is required to
identify the genes that are responsible for the clinical phenotypes
observed in Monosomy 21 patients.
In parallel with the analysis of the genomes of patients with
Monosomy 21 several mouse models of this condition have been
developed [11,12,13,14]. Synteny exists between human chromo-
some 21 (HSA21) and mouse chromosomes 16 (MMU16), 17
(MMU17) and 10 (MMU10). Specifically, about 23.2 Mb of
human chromosome 21, from 21q11.2 to 21q22.3, is homologous
to C3.1-C4 on MMU16, 1.1 Mb of 21q22.3 is homologous to the
B1 band on MMU17 and 2.3 Mb of 21q22.3 region is syntenic to
C1 on MMU10. A mouse model carrying a heterozygous deletion
of MMU16 syntenic to the human region 21q22.12-q22.3
displayed reduced overall brain and hippocampus volume, but
increased cerebellum volume. Nevertheless, these changes did not
show any correlation with abnormal functioning of the hippo-
campus measured in the Morris water maze assay or by
electrophysiology [13]. A mouse carrying a heterozygous 0.5 Mb
deletion of MMU10, syntenic to the distal part of human region
21q22.3 located between the PRMT2 and COL6A1 genes, showed
no gross morphological or behavioral anomalies, but exhibited an
increased inflammatory reaction after intranasal lipopolysaccha-
ride (LPS) administration [12]. In contrast, a mouse carrying a
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heterozygous 2.3 Mb deletion of MMU10, syntenic to the human
region located between the PRMT2 and PDXK genes, showed
similarities to Monosomy 21-associated intellectual disability (with
impairments in learning and memory), as did a mouse carrying a
heterozygous deletion of a 1.1 Mb segment on MMU17, syntenic
to the human region located between the ABCG1 and RRP1B
genes [14]. Interestingly, 13 out of 41 syntenic genes located on
mouse chromosome 10, namely the genes located between the
Prmt2 and Col6a1, might be excluded as potential candidates for
partial Monosomy 21-associated intellectual disability as deletion
of these genes did not result in learning impairment in mice [12].
To our knowledge all currently available Monosomy 21 mouse
models provide phenotypic data only on deletions syntenic to
human regions located between 21q21.3 and the telomere
[11,12,13,14]. Thus, the contribution of additional regions/genes
to Monosomy 21 remains unclear. To study this, we used
chromosome engineering to generate a new mouse model of
Monosomy 21, Ms(Lipi-Usp25)1Dja (abbreviated as Ms1Dja),
carrying a deletion syntenic to 21q11.2-q21.1 in human, to assess
the contribution of the 6 genes in this 1.6 Mb interval to the
development of clinical features found in patients with Monosomy
21.
Results
Generation of monosomic mice for the 1.6 Mb Lipi-Usp25
region
The Lipi and Usp25 genes are located at the proximal and distal
ends of a 1.6 Mb region in the C3.1 band of MMU16, which is
syntenic to 21q11.2-q21.1 in humans (Figure 1). This region on
HSA21 contains 8 genes (NCBI build h36), whereas the syntenic
region in MMU16 contains only 6 genes (NCBI build m37)
orthologous to their HSA21 counterparts as there are no
annotated murine orthologs of ABCC13 and AF165138.1. To
generate the deletion we used chromosomal engineering [15].
Briefly, E14TG2a ES cells were sequentially electroporated with
targeting vectors containing a portion of the Hprt selection cassette
(59 or 39 Hprt), a loxP site and a coat color marker (Agouti or
Tyrosinase). The targeting vector containing the 59 Hprt cassette
(MICER clone: MHPN69h23 [16] was inserted proximal to Lipi
and the targeting vector containing the 39 Hprt cassette (pUSP-
3HPAg) was inserted distal to Usp25 (Figure 2A). The correct
insertion of both targeting vectors was confirmed by Southern blot
analysis on StuI- or BamH1-digested gDNA from ES clones using a
59 and 39 Southern external probe, respectively (Figure 2B). ES
cell clones that were targeted on the same chromosome (in cis)
were electroporated with a Cre-expression vector, and selected in
medium with hypoxanthine, aminopterin and thymidine (HAT) to
isolate ES clones carrying a chromosomal deletion generated via
loxP sites recombination (Figure 2A). The deletion allele was
designated Ms(Lipi-Usp25)1Dja (abbreviated as Ms1Dja). The
presence of the deletion in Hprt-resistant ES clones was confirmed
by fluorescence in situ hybridization (FISH) (Figure 2C). The
positive ES clones were injected into C57BL/6-Tyrc-Brd blastocysts
to generate chimeras, which transmitted the Ms1Dja allele to their
progeny. After the germline transmission, monosomic mice were
backcrossed to and maintained on the C57BL/6-Tyrc-Brd back-
ground.
Homozygous deletion of the Lipi–Usp25 region results in
embryonic lethality. Monosomic (heterozygous) Ms1Dja mice
were viable and fertile and did not show any overt phenotypic
abnormalities. In intercrosses of monosomic Ms1Dja mice, no
nullisomic (homozygous) Ms1Dja mice were recovered at birth out
of 47 animals generated (Figure 3A). To determine the age of
embryonic lethality of the nullisomic mice, embryos from
monosomic intercrosses were collected at different timepoints
during gestation (E10.5, E12.5 and E14.5). Nullisomic embryos
were identified at E10.5 at low but still within normal Mendelian
ratios (8/52 embryos), whereas only one very necrotic one was
found at E12.5 (1/40 embryos, P,0.01), although increased
numbers of reabsorbed embryos were observed, and none were
recovered at E14.5 (0/32 embryos, P,0.01); Figure 3A. Even at
E10.5, the nullisomic embryos were markedly smaller than their
littermates (Figure 3B) and showed an increased number of
apoptotic cells in the neural tube (as determined by hematoxylin
and eosin-stained sections and Cleaved Caspase-3 immuno-
histochemistry; Figure 3C) with prominent degeneration of the
neural tube as well as some other embryonic structures. This
indicates that the majority of embryonic lethality in the nullisomic
embryos happened on or before day E10.5 and was probably due to
a defect in neural tube formation.
Phenotyping and dysmophology analysis of monosomic
Ms1Djamice. To determine whether clinical features of patients
with Monosomy 21 could be observed in the monosomic Ms1Dja
mice, 14 monosomic mice and 14 of their wildtype littermates fed a
high-fat diet (HFD) from the age of 4 weeks were subjected to a
series of tests designed to analyze their morphology, motor skills,
behavior, neuromuscular function, pain perception, hearing,
metabolism and hematology. Table S1 provides a short
summary of the phenotypic tests performed. The monosomic
mice were viable, fertile and did not show any overt phenotype upon
observation. They showed no gross motor or neurological
abnormalities and had a similar level of pain perception, muscle
strength and hearing compared with control animals (wildtype
littermates), showing that the monosomic mice had no gross
behavioral or neuromuscular defects.
The general dysmorphology and eye morphology tests only
found a difference between the controls and monosomic mice with
respect to eye pigmentation. Pigmentation of the eyes and
abnormal iris pigmentation was observed in albino monosomic
mice. However, this can be explained by the presence of coat
colour markers (tyrosinase and agouti) present in the constructs
used for gene-targeting in the ES cells. Thus, it was concluded that
the monosomic mice showed no gross dysmorphology.
Behavioral phenotyping of monosomic Ms1Dja mice
To further explore behavioral and cognitive function, 12
monosomic mice and 12 wildtype littermate controls were
subjected to an elevated plus maze assay to test for anxiety, and
a social recognition paradigm with a long-term social memory
component. Both monosomic and wildtype animals showed a
preference for the closed arm compared to the open arm of the
elevated plus maze, as measured by the amount of time spent in
the open arm, and the number of entries into the open and closed
arm (Figure 4A, 4B, 4C; two-way ANOVA: repeated measures
for Trial, F4,64 = 25.86, P,0.0001, effect for genotype F1,64 = 11.26,
P=0.943). The social recognition test showed that the monosomic
animals were able to recognize two different (sedated) male
stimulus animals (mouse A and mouse B) (Figure 5A; two-way
ANOVA: repeated measures for Trial, F4,64 = 25.86, P,0.0001,
trial 4 vs trial 5, P,0.05, post hoc analysis). Both groups of mice had
similar initial levels of investigation, and spent increasingly lower
amounts of time investigating the repeatedly presented stimulus
animal (mouse A) (Figure 5A; two-way ANOVA effect for genotype
F1,64 = 11.26, P=0.943, interaction Trial6genotype F4,64 = 1.762,
P=0.1475). Both of these results suggest normal levels of anxiety
and social interaction. However, when subjected to a 24- hour
social memory retention test, monosomic mice were less capable of
21q11.2-q21.1 Haploinsufficient Genes
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distinguishing a familiar stimulus animal (mouse A) from an unfamiliar
one (mouse C) (Figure 5C; ratio of investigation het vs wt, P,0.05
compared with two-tailed Student’s t-test). Wildtype animals, in
contrast, retained the memory of the familiar stimulus animal (mouse
A) and investigated it less frequently. To ensure this deficit was
cognitive, and not simply a consequence of diminished olfactory
capacity in monosomic Ms1Dja mice, we ascertained whether they
could recognize odors in the absence of other sensory cues. Indeed,
monosomic and wildtype animals were equally capable of detecting
odors and of discriminating between them (Figure S1).
Analysis of the body composition of monosomic Ms1Dja
mice
Analysis of the body fat composition and bone mineral density of
the mice by dual energy X-ray absorptiometry (DEXA) revealed that
monosomic mice exhibited a statistically significant increase in fat
mass and fat percentage estimate compared with controls (Figure 6).
It is important to note that this was not due to any significant
differences in the weight of the monosomic mice from the controls
(data not shown). However, despite the increased fat deposition in the
monosomic mice, indirect calorimetry and glucose tolerance tests, as
well as the analysis of whole blood and plasma clinical chemistry
parameters, including the analysis of the triglycerides, cholesterol,
non-esterified free fatty acids, and low and high density lipoproteins,
revealed no significant differences between the monosomic mice and
controls (data not shown). There was also no significant difference in
food intake between the two groups.
Thus taken together, we conclude that whereas monosomy of
the Lipi–Usp25 region does not have a dramatic impact on
morphology, motor skills, behavior, whole-body metabolism and
hematological parameters, it does appear to affect memory
retention and the deposition and/or metabolism of fat.
Increased body fat percentage in monosomic mice fed on
a high-fat diet. Following on from the preliminary DEXA
results that suggested that monosomic mice fed on a high-fat diet
(HFD) exhibit a statistically significant increase in fat mass/fat
percentage estimate at 14 weeks, we analyzed monosomic and
Figure 1. Schematic representation of HSA21 and the syntenic region on MMU16. The endpoints of the syntenic regions are indicated (Lipi
and Usp25). Genes that map to the human 21q11.2-q21.1 region (NCBI build h36) and the C3.1 band on MMU16 (NCBI build m37) are listed. Studies
describing partial Monosomy 21 patients with deletions involving the 21q11.2-q21.1 region (as indicated by the length of the black line) are shown.
doi:10.1371/journal.pone.0029681.g001
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control mice fed on a HFD at additional time points, namely at 8
and 25 weeks. As expected both monosomic and control mice
showed a gradual increase in fat mass/fat percentage estimate with
age (Figure 7A). However, the monosomic mice showed a
significantly higher increase in fat mass/fat percentage estimate
compared with controls (at both 8 and 25 weeks of age).
We next compared the average weight of the two groups of mice
at each time point to see if the increase in fat mass/fat percentage
estimate was reflected in the overall body weight gain (Figure 7B).
Whilst no significant differences were observed in the average
weight of the monosomic mice compared with controls at 8 and 14
weeks of age, the 25-week old monosomic mice showed a
significant increase in body weight over the controls (Figures 7B
and 7C). The body weight gain observed in 25-week old
monosomic mice is most likely due to their increased fat deposition
as their lean mass was not significantly changed when compared to
the controls (Figure 7D). This increased fat deposition resulted in
fatty changes in the livers of the mice, with severe to very severe
fatty changes observed in the monosomic mice compared to only
mild to moderate fatty changes in controls (Figure 7E). Similarly,
25-week old monosomic mice fed on a HFD showed a markedly
thicker layer of subcutaneous fat and enlarged adipose cells in the
skin compared with controls (Figure 7E).
The increased fat deposition in monosomic mice is diet-
induced. In order to determine if the HFD was the causal factor
for the increased fat deposition, monosomic and control mice were
fed on a normal-fat diet (NFD) were subjected to DEXA analysis
at 8 and 25 weeks (Figure 8). At 8 weeks of age, the monosomic
mice showed a significant increase in fat percentage estimate
compared to controls, although this increase was more obvious on
a HFD. However, NFD monosomic mice at 25 weeks of age did
not show a significantly increased fat mass/fat percentage estimate
compared with the littermate controls. Concomitant with this, 1-
year old monosomic also did not show a significant increase in fat
mass/fat percentage estimate compared with controls. Similarly,
histopathological analysis of the livers from NFD monosomic mice
at 8-, 25-weeks and 1-year of age exhibited comparable levels of
fatty changes with those observed in the controls, as no fatty
changes were seen in livers of either monosomic or wildtype mice
at either 8 or 25 weeks of age, and at 1 year the degree of hepatic
fatty change ranged from mild through moderate to severe in both
monosomic and wildtype mice (data not shown). Thus, it seems the
HFD is the causal factor of the increased fat mass/fat percentage
estimate in monosomic mice.
Expression analysis of the genes from the deleted
Lipi2Usp25 interval in subcutaneous adipose tissue. We
Figure 2. Generating a 1.6 Mb deletion between the Lipi and Usp25 loci. (A) The targeting vectors contain a loxP site (arrowhead), a
selectable antibiotic resistance gene (N (neomycin) or P (puromycin)), a coat color marker (Ty or Ag) and part of the Hprt gene (59 or 39) were targeted
as shown. The colored boxes (green and red) indicate the location of the probes (59 and 39, respectively) used for Southern blotting (B) The targeting
events were confirmed by Southern blot analysis showing an additional StuI fragment of 17 kb compared with the wildtype allele (15 kb) for the Lipi
locus and an additional BamHI fragment of 22.6 kb compared with the wildtype allele (12 kb) for the Usp25 locus. B, BamHI; S, StuI; P, puromycin; N,
neomycin; Ty, Tyrosinase; Ag, Agouti. (C) Interphase FISH analysis with BAC probes that map in the region of the deletion (red) and outside (green).
Chromosomes from the ES cells double-targeted in cis (Ms1Dja/+) showed two green and only red signal due to the deletion of the Lipi–Usp25 region,
while chromosomes from the wildtype ES cells showed two green and two red signals.
doi:10.1371/journal.pone.0029681.g002
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performed quantitative RT-PCR (qRT-PCR) to investigate whether
any of the six genes from the deleted Lipi2Usp25 interval showed a
differential expression between adipocytes from monosomic and
control mice fed on a HFD (n=8 per genotype at 16 weeks of age).
Of the genes analyzed by qRT-PCR, four were significantly down-
regulated (Hspa13, Samsn1, Nrip1 and Usp25; P=0.0007, P=0.0057,
P=0.0361 and P=0.0379, respectively; Figure S2), and two were
not expressed in adipose tissue (Lipi and Rbm11).
Discussion
We report on the generation and phenotypic characterization of
the monosomic Ms1Dja mouse, a model of Monosomy 21 covering
the 1.6 Mb Lipi–Usp25 region. The deleted interval is syntenic to
the centromeric part of the HSA21, and contains 6 genes that are
conserved between human and mouse. Homozygous deletion of
this region (nullisomy) resulted in mid-gestational embryonic
lethality mostly due to neural tube degeneration with evidence of
prominent apoptosis, indicating that at least one of the genes in
this region is required for development and maintenance of the
neural tube. However, as none of the 6 genes in this region have
been reported to be involved in neural tube development (and all
are normally expressed in the developing brain of the mouse
embryo at both E9.5 and E10.5 [17], it is hard to speculate which
gene (or genes) might be responsible. However, given that
Figure 3. Embryonic lethality of mice homozygous for the Lipi-Usp25 deletion. (A) Genotyping of E10.5, E12.5, E14.5 embryos, and 3-week
old mice from monosomic Ms1Dja intercrosses. Asterisk indicates P,0.01 (Chi-square test). (B) Photos of wildtype (+/+), monosomic (Ms1Dja/+) and
nullisomic (Ms1Dja/Ms1Dja) embryos at E10.5. Longitudinal measurements are 4 mm, 4 mm and 2.7 mm for the wildtype, monosomic and nullisomic
embryos, respectively. (C) Immunohistochemical analysis using a Cleaved Caspase-3 (Asp175) antibody showed markedly increased number of
apoptotic cells (brown staining; highlighted by black arrows) in the neural tube of nullisomic (Ms1Dja/Ms1Dja) E10.5 embryos. Images are
representative and taken at6200 magnification.
doi:10.1371/journal.pone.0029681.g003
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homozygous null Samsn1 and Nrip1 mice are viable [18,19], it is
unlikely that loss of these genes causes the embryonic lethality
observed.
Detailed phenotypic analysis of monosomic Ms1Dja mice, found
them to be viable, fertile, and to display no obvious differences
from wildtype littermate controls in terms of morphology, motor
skills, gross behavior, and both clinical chemistry and hematolog-
ical parameters were normal. They did, however, show deficits in
long-term memory retention in a socially relevant testing
paradigm. Social recognition is hippocampus-dependent [20]
and has been used for learning and memory testing [21,22] and
for assessing cognitive impairment in mice [23]. Thus haploinsuf-
ficiency of the genes mapped within the deletion may contribute to
the intellectual disability of humans with Monosomy 21, but they
do not model the other clinical phenotypes commonly seen in
Monosomy 21 patients. However, given all currently known
Monosomy 21 patients with ‘‘centromeric’’ deletions carry
rearrangements spanning much larger regions of HSA21 than
represented in our model, we cannot rule out the possibility that
genes in the Lipi-Usp25 region work in synergy contribute to the
cognitive phenotype observed in these patients. In addition, there
are 2 genes in the 21q11.2-q21.1 region of HSA21 for which there
are no mouse orthologs annotated, namely ABCC13 and
AF165138.7. Our model does not account for the possible roles
that these genes may play in Monosomy 21.
Monosomic mice fed a HFD showed significantly increased fat
percentage estimates at 8, 14, and 25 weeks of age compared with
controls. However, these significantly increased fat percentage
estimates over controls were not observed when the monosomic
mice were fed a NFD (except at 8 weeks of age, which might be
considered as an early phenotype variation). Considering the fact
that the overall fat percentage estimate was much higher in both
groups of mice on a HFD (containing 21% crude fat) compared to
a NFD (containing 9% crude fat), the HFD can be regarded as an
environmental factor that increases fat percentage estimates in the
mice. Given that monosomic mice showed significantly higher
percentage fat estimates than wildtype controls, it is clear that
there is also a genetic factor affecting this phenotypic change.
However, although the interaction between genetic susceptibility
loci and environmental factors in the development of obesity have
been shown in different analyses performed both in humans and
mice [24,25,26,27,28,29,30], to our knowledge, this interaction
has not been shown before in patients with deletions encompassing
the 21q11.2-q21.1 region.
Although four published studies have reported on the presence
or absence of obesity in Monosomy 21 patients with deletions
encompassing the 21q11.2-q21.1 region [4,31,32,33], only one
found a positive correlation; two cases that presented with mild
intellectual disability, some facial abnormalities, and obesity [33].
Unfortunately, without knowledge of the diet of these individuals,
we can only speculate whether the observed obesity in these
patients was diet induced.
There are 6 genes that are conserved between human and
mouse in the Lipi-Usp25 region: Lipi, Rbm11, Hspa13, Samsn1, Nrip1
and Usp25. To investigate potential molecular mechanisms leading
to HFD-induced obesity in monosomic Ms1Dja mice, we
performed qRT-PCR analysis on all the genes from the deleted
interval in adipocytes from monosomic and wildtype littermates.
We found four of them to show a significant down-regulation in
monosomic mice relative to controls (Hspa13, Samsn1, Nrip1 and
Usp25) and two of them were not expressed in subcutaneous
adipose tissue (Lipi and Rbm11). However, as none of the four
genes expressed in adipocytes have been reported to be involved in
the regulation of adipocyte metabolism, it is hard to speculate if
any of the down-regulated genes might be responsible for HFD-
induced increase in fat deposition our monosomic mice.
To-date, homozygous null mice for Samsn1 and Nrip1 [18,19]
and a mouse model carrying a deletion of the exon 10 of the
mutant Lipi (Lpd, Lpdl) locus [34] have been generated. Samsn1
knockout mice were viable and did not show any overt phenotypic
abnormalities, but displayed enhanced adaptive immunity [19].
However, body weight and resistance to HFD-induced obesity and
hepatic steatosis have not been specifically analyzed in either
heterozygous or homozygous Samsn1 mice. Homozygous Nrip1
Figure 4. Elevated plus maze test. (A) Percentage of time spent in the open arms. (B) Number of entries into the open arms. (C) Number of
entries into the closed arms. Both monosomic (Ms1Dja/+, n = 12) and control (+/+, n = 12) mice spent similar amount of time in the open arms and
had comparable number of entries into the open and closed arms. Tested with two-tailed Student’s t-test. The error bars represent the standard error
of the mean.
doi:10.1371/journal.pone.0029681.g004
21q11.2-q21.1 Haploinsufficient Genes
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e29681
(Nrip12/2) mice fed a NFD showed a 20% reduction in body
weight and remained leaner than controls even when fed a HFD,
despite the fact that Nrip1 affects the function of adipose tissue by
blocking both mitochondrial respiration and energy uncoupling
and prevents expression of key regulatory genes in white adipose
tissue (WAT) [35]. In addition, Nrip12/2 mice were resistant to
both age-induced hepatic steatosis and HFD-induced fatty
changes in the liver (although this could be explained by the
increased expression of genes involved in energy expenditure and
mitochondrial uncoupling, and the decreased expression of genes
encoding lipogenic enzymes) [35]. However, body weight and
resistance to HFD-induced obesity and hepatic steatosis was only
demonstrated in Nrip12/2 mice and Nrip1+/2 animals have not
been studied. Homozygous Lipi (Lipilpd1/Lipilpd1) mice fed on a
NFD showed hepatic steatosis and hypertriglyceridemia, while
heterozygous Lipi (Lipilpd1/+) mice did not display any of such
phenotypic abnormalities [34]. No data for body weight or
resistance to HFD-induced obesity have been available for either
Lipilpd1/Lipilpd1 or Lipilpd1/+ mice. Interestingly, sequencing of the
human LIPI (LPDL) gene in 186 individuals with hypertriglycer-
idemia and 232 controls identified a nonsynonymous coding SNP
164G.A (C55Y) in two patients withhypertriglyceridemia,
indicating that this rare missense mutation in the exon 2 of the
LIPI gene might be associated with an elevated triglycerides level
[34]. To that end, we evaluated the level of triglicerides in
monosomic Ms1Dja and wildtype littermates, but observed no
significant differences between monosomic mice and controls. As
none of the other 3 genes in the Lipi-Usp25 region are known to be
involved in lipid and carbohydrate metabolism or maintenance of
energy homeostasis, it is difficult to hypothesize which gene (or
genes) is responsible for HFD-induced increase in fat deposition
and fatty changes in livers of our monosomic mice. Importantly,
although the Ms1Dja mice were backcrossed to C57BL/6-Tyrc-Brd
for several generations prior to phenotyping, they will retain some
ES derived 129P2/OlaHsd DNA linked to the targeted locus that
may carry with it variants that contribute to the phenotypes we
observe here.
Monosomy 21 is a rare human disease with variable clinical
appearances due to differing gene dosage errors on chromosome
21 resulting in phenotypes including intellectual disability,
dysmorphology, and cardiac and/or renal abnormalities
[5,6,7,8,9]. Attempts to generate genotype-phenotype correlations
Figure 5. Social recognition test. (A) Habituation-dishabituation test. Both monosomic (Ms1Dja/+, n = 10) and control (+/+, n = 8) mice recognized
two different stimulus animals (mouse A and mouse B), as shown by decline in the investigation time over trials 1 to 4 when they were repetitively
presented the same (familiar) stimulus animal (mouse A) and increase in the investigation time on trial 5 when they were presented with a novel
stimulus animal (mouse B) (trial 4 vs trial 5, *** P,0.0001, post-hoc analysis after two-way ANOVA, the error bars represent the standard error of the
mean). (B) Discrimination test. 24 hours after the habituation-dishabituation test. When given a choice between the familiar stimulus mouse (mouse
A, thus the mouse used for trials 1 to 4 on day 1) and a new unfamiliar mouse (mouse C), control mice spent significantly less amount of time
investigating the familiar stimulus mouse (mouse A) than the unfamiliar one (mouse C). Monosomic (Ms1Dja/+) did not recognize the familiar from
the unfamiliar animal, shown by a familiarity ratio close to 0.5 (‘‘chance’’, dotted line). Control animals had a significantly smaller familiarity ratio than
monosomic (Ms1Dja/+) mice (two-tailed Student’s t-test, the error bars represent the standard error of the mean). Five animals (two mutants and
three wildtypes) were taken out of the analysis because of their low investigation times (less than 10 seconds on trial 1).
doi:10.1371/journal.pone.0029681.g005
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in this disease have been complicated by both the small number of
patients available for study (there is a lack of informative sets of
partial Monosomy 21 patients [7]) and the fact that some patients
with Monosomy 21 also carry anomalies involving other human
chromosomes, such as segmental trisomies and deletions [7,36].
We show here that haploinsufficiency of a gene (or genes) in the
Lipi-Usp25 region of MMU16, syntenic to human 21q11.2-q21.1,
results in a high-fat diet-induced increase in fat deposition and a
deficit in memory retention in monosomic mice. Further studies
will be required to understand the molecular causes of these
phenotypes.
Materials and Methods
Ethics Statement
Experiments were approved by both the Home Office, and the
Local Institutional Ethics Committee.
Gene targeting in ES cells and generation of deletion
mice
The 59HPRT MICER targeting vector MHPN69h23 [16] was
linearized with NheI and electroporated into E14Tg2a ES cells
(129P2/OlaHsd) which were cultured as described previously
[37]. Stable integrants were selected in 175 mg/ml G418. Positive
clones were identified by Southern blotting on StuI-digested gDNA
(using a probe amplified from E14Tg2a gDNA using primers: 59-
AGG CAA AAA CCA AGA CCT CA-39 and 59-ATG GTG
GCA ATG TTC TCA CA-39). The 39HPRT targeting vector
(pUSP-3HPAg) was constructed using recombineering to capture
a 6,963 bp fragment telomeric to Usp25 from 129Sv BAC clone:
bMQ134j07 [38]. The 39 recombineered targeting vector was
linearized with SwaI and electroporated into MHPN69h23-
targeted ES cells, which were subsequently selected in 3 mg/ml
puromycin. Southern blotting was performed on BamHI-digested
DNA (using a probe amplified from E14Tg2a gDNA using
primers: 59-GTG CCC ACA TGG TTT TCT TT-39 and 59-
CAA CTC TCG CCT CAC ACA AA-39). To determine if the
59HPRT and 39HPRT targeting vectors were targeted in cis- or in
trans- we electroporated double-targeted ES cell clones with the
pOG231 Cre-expression vector [39] and selected them in
hypoxanthine, aminopterin, and thymidine (HAT) medium as
described previously [40,41]. Clones of ES cells that carried the
desired deletion between Lipi and Usp25 generated by cis-
recombination were identified and confirmed by PCR using the
primers: 59-AAG GGT GTT TAT TCC CCA TGG ACT AAT
TAT G-39 and 59-CCT TCA TCA CAT CTC GAG CAA GAC
GTT CAG-39 (presence of a 1.7 kb band confirmed the cis
orientation). The deletion allele was designated Ms(Lipi-
Usp25)1Dja (abbreviated as Ms1Dja). ES cell clones carrying
Ms1Dja were injected into C57BL/6-Tyrc-Brd blastocysts and
transmitted through the germline. After the germline transmission
of the deletion allele from the chimeric founder mice, the
monosomic mice were backcrossed to and maintained on a
C57BL/6-Tyrc-Brd background. All mice were housed and
procedures carried out in accordance with Home Office guidelines
(United Kingdom). Experiments were approved by both the Home
Office, and the Local Institutional Ethics Committee.
Fluorescent in situ hybridization (FISH)
Chromosome spreads of activated splenocytes were performed
as described previously [42]. Mouse BAC clones were chosen to be
located inside (RPCI24-200E18) or outside (RPCI24-246B23) the
deletion region (http://bacpac.chori.org/mmouse24.htm). One
microgram of mouse BAC DNA was used to generate DNA
probes labeled by nick translation with DIG-dUTP (for 246B23)
and biotin-dUTP (for 200E18). Detection was achieved by the use
of both antidigoxigenin-rhodamine and avidin-fluorescein anti-
bodies (Vector Laboratories, Peterborough, UK). Chromosomes
were counterstained with DAPI (49,6-diamidino-2-2-phenylindole;
Vector Laboratories).
Histology and immunohistochemistry
Tissues and embryos (E10.5, E12.5 and E14.5) were fixed in
10% neutral buffered formalin for 24 hr, embedded in paraffin
and 5 mm sections cut and stained with hematoxylin and eosin.
Immunohistochemistry was performed on formalin-fixed, paraffin-
embedded embryos using a Cleaved Caspase-3 (Asp175) (Cell
Signaling, Hitchin, UK) primary antibody, which was detected
using the rabbit VECTASTAINH Elite ABC Kit (Vector
Laboratories, UK) and DAB Substrate Kit for Peroxidase (Vector
Laboratories, UK).
Phenotypic Assays
Complete details of all phenotypic tests performed are listed on
the Wellcome Trust Sanger Institute Mouse Resources Portal
(http://www.sanger.ac.uk/mouseportal/).
Diet challenge. At 4 weeks of age mice were randomly
divided into two groups, and either maintained on standard
Figure 6. Fat percentage estimate of 14-week old control and monosomic mice fed a high-fat diet. DEXA results showing fat percentage
estimate in 14-week old male (n = 7) and female (n = 7) control (+/+) and male (n = 7) and female (n = 6) monosomic (Ms1Dja/+) littermates fed a high-
fat diet. Asterisks indicate statistical significance (two-tailed Student’s t-test). The error bars represent the standard deviation of the measurements.
doi:10.1371/journal.pone.0029681.g006
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Figure 7. Analysis of high-fat diet-fed monosomic mice at different ages. DEXA results showing (A) fat percentage estimate and (B) body
weight measurements in 8-, 14- and 25-week old male (n = 8, n = 7 and n= 8, respectively) and female (n = 8, n = 7 and n= 10, respectively) control (+/
+) and male (n = 9, n = 7 and n= 7, respectively) and female (n = 10, n = 6 and n= 9, respectively) monosomic (Ms1Dja/+) littermates fed a high-fat diet.
Asterisks indicate statistical significance (two-tailed Student’s t-test). The error bars represent the standard deviation of the measurements. (C) Photos
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laboratory chow (a ‘normal-fat diet’ containing not less than 9%
crude fat, 20% crude protein and 63% carbohydrate;
Autoclavable Mouse Breeder Diet 5021, Lab Diet, London, UK)
or changed to a ‘high-fat diet’ containing 21.4% crude fat, 17.5%
crude protein and 50% carbohydrate (Western RD; Special Diets
Services, Essex, UK) until 25 weeks of age.
Dual energy X-ray absorptiometry (DEXA). At 8, 14, 25
or 52 weeks of age, the mice were euthanized, weighed and placed
on the PIXImus II Densitometer (GE Medical Systems,
Buckingshire, United Kingdom). The PIXImus software package
automatically analyses the resulting images, excluding the skull, to
calculate body fat mass (g), lean mass (g), fat percentage estimate
(%), bone area (cm2), bone mineral density (BMD) (g/cm2) and
bone mineral content (BMC) (g). Quality control using a phantom
was performed before imaging. Data was statistically analyzed
using two-tailed Student’s t-test.
Behavioral tests
Male monosomic Ms1Dja mice and male wildtype littermate
controls were 3- to 7-month old and were group housed from
weaning. All mice were prehandled for 1–2 minutes every day for
four days prior to testing for habituation.
Elevated plus maze. The elevated plus maze was made of
Plexiglas and homogeneously illuminated and tests performed
under dim light. The apparatus consisted of four arms (3065 cm)
elevated 40 cm above the floor. Two of the arms contained 15 cm-
high black walls (enclosed arms) and the other two none (open
arms). Each mouse was placed in the middle section facing an
open arm and left to explore the maze for a single 5-minute session
with the experimenter out of view. Testing apparatus and areas
were cleaned carefully between animals with a solution of 70%
ethanol (5%, v/v). All test sessions were recorded and subsequently
analyzed with Noldus Ethovision 3 video tracking software
(Tracksys Ltd., UK). The tracking system recorded time spent in
each arm and number of entries into each arm, considering an
animal inside a zone whenever its centre point is within.
Social recognition test. The test was performed under red
light, using 3 different 2-month old male stimulus mice (C57BL/
6NTac/USA; mouse A, 129P2/OlaHsd; mouse B, and C57BL/
6NTac/USA; mouse C) sedated with ketamine/xylazine (i.p. 1 g/
0.1 g per kg of body weight). Test mice were first habituated for
10 minutes to a test arena identical to their home cage. On day 1,
for the habituation-dishabituation test, a stimulus mouse A was
placed into the test arena for 1 minute. The same stimulus mouse
A was subsequently presented four times at 10 minutes intervals.
In the fifth trial, a stimulus mouse B was presented for 1 min. On
day 2, for the discrimination test, the animals were simultaneously
presented with stimulus mouse A (familiar animal that was
encountered on trials 1–4 on day 1) and mouse C (new unfamiliar
animal) for 2 minutes. All trials were recorded with an overhead
camera and the videos were subsequently scored blind of genotype
using a handheld stopwatch. The amount of time the test animal
spent investigating, by direct oronasal contact or close approach
(,1 cm), sniffing towards the stimulus mice A and C, was
recorded. If the test animal spent longer investigating a novel
stimulus animal (mouse C) than the familiar one (mouse A), this
of 25-week old male and female control (+/+) and monosomic (Ms1Dja/+) littermates fed a high-fat diet. (D) DEXA results showing lean mass
measurements in 25-week old male (n = 8) and female (n = 10) control (+/+) and male (n = 7) and female (n = 9) monosomic (Ms1Dja/+) littermates fed
a high-fat diet. Analyzed with two-tailed Student’s t-test. The error bars represent the standard deviation of the measurements. (E) Haematoxylin and
eosin-stained liver and skin sections from 25-week old wildtype (+/+) and monosomic (Ms1Dja/+) littermates fed a high-fat diet. Note markedly
increased number and size of adipose cells in liver sections from monosomic (Ms1Dja/+) mice compared to wildtype (+/+) littermates (highlighted by
black arrows). Images are representative and taken at6100 magnification.
doi:10.1371/journal.pone.0029681.g007
Figure 8. Fat percentage estimate of control and monosomic mice fed a normal-fat diet. DEXA results showing fat percentage estimate in
8-, 25- and 52-week old male (n = 8, n = 10 and n= 6, respectively) and female (n = 8, n = 10 and n=8, respectively) control (+/+) and male (n = 9, n = 7
and n= 9, respectively) and female (n = 10, n = 9 and n= 9, respectively) monosomic (Ms1Dja/+) littermates fed a normal-fat diet. Asterisks indicate
statistical significance (two-tailed Student’s t-test).
doi:10.1371/journal.pone.0029681.g008
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was taken as evidence for social recognition. The familiarity ratio
was taken as the amount of time [sec] spent investigating the
familiar stimulus animal (mouse A) divided by the sum of time
spent investigating both stimulus mice A and C. These data are
presented as mean6 standard error of the mean and was analyzed
using GraphPad Prism software (GraphPad Software Inc.).
Statistical analysis for the habituation-dishabituation test data
was performed using a two-way ANOVA with repeated measures
for trial and genotype as factor and Tukey-HSD post hoc test.
Discrimination data was analyzed using two-tailed Student’s t-test
using the discrimination ratio.
Olfactory function test. Male mice were habituated for
10 minutes to a test arena identical to their home cage and tested
in 263 minutes trials with a 10 minutes interval. In trial 1,
262 cm2 filter papers were randomly placed at opposite ends of
the arena. One, the control, was swabbed in a clean cage and the
other, the stimulus, was swabbed in a cage housing C57BL/
6NTac/USA females. The amount of time investigating each
swab in 3 minutes was recorded. Male mice with the capacity to
perceive odors or pheromones can detect, and prefer to
investigate, female-derived olfactory stimuli. In trial two, both
filter papers were swabbed in a cage housing C57BL/6NTac/
USA female mice. The control swab had 20 ml water added while
the stimulus swab had 20 ml of a 1:100 dilution of almond extract
(Dr Oetker, Leeds, UK) in water. Mice with the capacity to smell
almond prefer to investigate the swab with the novel supplemental
odor. For each trial, the discrimination ratio was calculated as the
amount of time (seconds) spent investigating the stimulus swab
divided by the sum of time spent investigating both swabs. The
data was statistically analyzed using two-tailed Student’s t-tests.
RNA extraction and quantitative RT-PCR
Total RNA was extracted from abdominal subcutaneous
adipose tissue of 16-week old high fat diet-fed monosomic and
control mice (n = 8 per genotype) using TRIzol (Invitrogen,
Paisley, UK) according to the manufacturer’s instructions. RNA
was DNase treated using Turbo DNase (Ambion, Austin, TX) and
1 mg of total RNA was reverse transcribed using the SprintTM RT
Complete kit (Clontech, Mountain View, CA) according to the
manufacturer’s instructions. Quantitative PCRs performed with
SYBRH Green PCR Master Mix (Applied Biosystems) on the ABI
7900HT sequence detection system in accordance with the
manufacturer’s instructions. Primers are listed in Table S2. The
qPCR reactions were designed as: 50uC for 2 minutes, 95uC for
10 minutes, 40 cycles of (95uC for 15 seconds and 60uC for
1 minute), followed by 95uC for 15 seconds. The final quantifi-
cation was determined relative to the average CT of the house-
keeping genes Eif1a, Hprt and Gapdh [43]. Statistical analysis was
performed using two-tailed Student’s t-test.
Supporting Information
Figure S1 Olfactory function test. Both monosomic
(Ms1Dja/+, n = 12) and control (+/+, n = 2) preferentially
investigated novel odors when given a choice between an odorized
stimulus (left, female odors (FO); right, FO+almond extract) and a
control (left, clean cage; right, FO) in sequential trials. In both
trials, monosomic (Ms1Dja/+) and wildtype (+/+) animals were
able to distinguish the novel stimulus odor (discrimination ratio
.0.5, P,0.05 two-tailed Student’s t-test, the error bars represent
the standard deviation of the measurements). There was no
significant difference between the discrimination ratios with
respect to genotype (P.0.05 two-tailed Student’s t-test, the error
bars represent the standard error of the mean), suggesting
monosomic (Ms1Dja/+) mice are not deficient in detecting either
socially relevant (FO) or non-relevant (almond) odors.
(TIFF)
Figure S2 Quantitative RT-PCR (qRT-PCR) analysis of
the genes from the deleted Lipi2Usp25 interval in
adipocytes from HFD control (+/+) and monosomic
(Ms1Dja/+) mice (n=8 per genotype at 16 weeks). Asterisks
indicate statistical significance; * P,0.05, ** P,0.01 (two-tailed
Student’s t-test). The error bars represent the mean with 95%
confidence interval.
(TIFF)
Table S1 A summary of the panel of tests performed on
all mice in the study.
(DOCX)
Table S2 qPCR primer sequences.
(DOCX)
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